Table 1.

Characteristics of VA veterans diagnosed with diabetes and COVID-19

	Count (N = 64,892)	%
Female sex at birth	3,872	6
Age category, years
19–39	1,296	2
40–49	3,523	5
50–59	10,238	16
60–69	16,506	25
70–79	25,277	39
≥80	8,054	12
White (vs. not White)	42,553	66
Black (vs. not Black)	17,255	27
Hispanic (vs. not Hispanic)	5,812	9
BMI, kg/m2
<18.5	268	1
18.5–24.9	5,185	10
25–29.9	14,265	27
30–34.9	16,266	31
35–39.9	9,909	19
≥40	6,617	13
Tobacco use
Never	17,381	27
Former	31,466	48
Current	16,047	25
HbA1c, %
<7	32,692	50
7–7.9	15,067	23
8–8.9	8,079	12
≥9	9,056	14
Metformin	29,685	46
Sulfonylurea	12,298	19
Thiazolidinedione	2,075	3
DPP4i	5,810	9
GLP1-RA	4,737	7
SGLT2i	5,542	9
Insulin	18,521	29
ACEi	22,084	34
ARB	12,524	19
Statin	42,083	65
Platelet inhibitor	17,825	27
Hypertension	57,879	89
Cardiovascular disease	38,394	59
Congestive heart failure	12,587	19
eGFR, mL/min/1.73 m2
≥90	11,733	20
60–89	25,576	44
45–59	11,096	19
30–44	5,906	10
15–29	2,204	4
<15 or dialysis	1,595	3
Urban/rural/highly rural residence
Highly rural	739	1
Rural	19,974	31
Urban	44,154	68
Unknown	27	0
Outcomes
Hospital admission within 30 days	13,315	21
ICU admission within 30 days	4,265	7
Death within 30 days	4,943	8
Death by 10 March 2021	6,931	11